These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38741352)

  • 1. Walking time and genetic predisposition for Alzheimer's disease: Results from the HELIAD study.
    Sampatakakis SN; Mourtzi N; Charisis S; Mamalaki E; Ntanasi E; Hatzimanolis A; Ramirez A; Lambert JC; Yannakoulia M; Kosmidis MH; Dardiotis E; Hadjigeorgiou G; Megalou M; Sakka P; Scarmeas N
    Clin Neuropsychol; 2024 May; ():1-17. PubMed ID: 38741352
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic Predisposition for White Matter Hyperintensities and Risk of Mild Cognitive Impairment and Alzheimer's Disease: Results from the HELIAD Study.
    Sampatakakis SN; Mourtzi N; Charisis S; Mamalaki E; Ntanasi E; Hatzimanolis A; Ramirez A; Lambert JC; Yannakoulia M; Kosmidis MH; Dardiotis E; Hadjigeorgiou G; Sakka P; Scarmeas N
    Curr Issues Mol Biol; 2024 Jan; 46(1):934-947. PubMed ID: 38275674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk for Alzheimer's disease and adherence to the Mediterranean diet: results from the HELIAD study.
    Mamalaki E; Charisis S; Mourtzi N; Hatzimanolis A; Ntanasi E; Kosmidis MH; Constantinides VC; Pantes G; Kolovou D; Dardiotis E; Hadjigeorgiou G; Sakka P; Gu Y; Yannakoulia M; Scarmeas N
    Nutr Neurosci; 2024 Mar; 27(3):289-299. PubMed ID: 36961750
    [No Abstract]   [Full Text] [Related]  

  • 4. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
    BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic risk and hazard scores for Alzheimer's disease prediction.
    Leonenko G; Sims R; Shoai M; Frizzati A; Bossù P; Spalletta G; Fox NC; Williams J; ; Hardy J; Escott-Price V
    Ann Clin Transl Neurol; 2019 Mar; 6(3):456-465. PubMed ID: 30911569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of
    Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
    Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
    Gorijala P; Aslam MM; Dang LT; Xicota L; Fernandez MV; Sung YJ; Fan KH; Feingold E; Surace EI; Chhatwal JP; Hom CL; ; ; Hartley SL; Hassenstab J; Perrin RJ; Mapstone M; Zaman SH; Ances BM; Kamboh MI; Lee JH; Cruchaga C
    Alzheimers Dement; 2024 Feb; 20(2):1038-1049. PubMed ID: 37855447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma GSH levels and Alzheimer's disease. A prospective approach.: Results from the HELIAD study.
    Charisis S; Ntanasi E; Yannakoulia M; Anastasiou CA; Kosmidis MH; Dardiotis E; Hadjigeorgiou G; Sakka P; Veskoukis AS; Kouretas D; Scarmeas N
    Free Radic Biol Med; 2021 Jan; 162():274-282. PubMed ID: 33099001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
    Najar J; Thorvaldsson V; Kern S; Skoog J; Waern M; Zetterberg H; Blennow K; Skoog I; Zettergren A
    Neurobiol Dis; 2023 Dec; 189():106357. PubMed ID: 37977433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults.
    Thompson LI; Cummings M; Emrani S; Libon DJ; Ang A; Karjadi C; Au R; Liu C
    J Prev Alzheimers Dis; 2024; 11(1):79-87. PubMed ID: 38230720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.
    Stocker H; Perna L; Weigl K; Möllers T; Schöttker B; Thomsen H; Holleczek B; Rujescu D; Brenner H
    Mol Psychiatry; 2021 Oct; 26(10):5812-5822. PubMed ID: 32404947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenome-Wide Association Study of Polygenic Risk Score for Alzheimer's Disease in Electronic Health Records.
    Fu M; ; ; Chang TS
    Front Aging Neurosci; 2022; 14():800375. PubMed ID: 35370621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer's Disease between the Chinese and European Populations.
    Li F; Xie S; Cui J; Li Y; Li T; Wang Y; Jia J
    J Prev Alzheimers Dis; 2024; 11(3):701-709. PubMed ID: 38706286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the Association Between Polygenic Risk Scores for Alzheimer's Disease With Cognitive Performance and Intrinsic Functional Connectivity in Healthy Adults.
    Ibnidris A; Fußer F; Kranz TM; Prvulovic D; Reif A; Pantel J; Albanese E; Karakaya T; Matura S
    Front Aging Neurosci; 2022; 14():837284. PubMed ID: 35645768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic score modifies risk for Alzheimer's disease in
    Huq AJ; Fulton-Howard B; Riaz M; Laws S; Sebra R; Ryan J; ; Renton AE; Goate AM; Masters CL; Storey E; Shah RC; Murray A; McNeil J; Winship I; James PA; Lacaze P
    Alzheimers Dement (Amst); 2021; 13(1):e12226. PubMed ID: 34386572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probability of Alzheimer's disease based on common and rare genetic variants.
    Escott-Price V; Schmidt KM
    Alzheimers Res Ther; 2021 Aug; 13(1):140. PubMed ID: 34404470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic risk of Alzheimer's disease in the Faroe Islands.
    Johansen M; Joensen S; Restorff M; Stórá T; Christy D; Gustavsson EK; Bian J; Guo Y; Farrer MJ; Petersen MS
    Eur J Neurol; 2022 Aug; 29(8):2192-2200. PubMed ID: 35384166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.